CannaRoyalty Corp.  and Aequus Pharmaceuticals Inc. today announced a collaboration (the “JV”) to advance a suite of cannabis-based therapies targeting neurological disorders into clinical trials in Canada, in collaboration with Canadian doctors and key opinion leaders. CannaRoyalty and Aequus have formed this collaboration to clinically advance a number of cannabis-based therapies in partnership with Canadian clinicians to create truly differentiated products supported by…
Read More

MSFHR Appoints Dr. Bev Holmes as President & CEO

The Michael Smith Foundation for Health Research (MSFHR) Board is pleased to announce that following an executive search process, Dr. Bev Holmes has been appointed as president and CEO. With an eight-year history of leadership within MSFHR, Bev is ideally suited to lead MSFHR as we grow our role as BC’s expert health research funding agency, and continue to develop…
Read More
Chinese hamster ovary (CHO) cells are the most widely used cell types for the production of therapeutic proteins in the biotechnology industry. These cells are grown in large vessels known as bioreactors, and the eventual productivity of industrial bioprocesses depends largely on maintaining healthy productive cells. The main mechanism by which cells lose their viability is known as apoptosis, which…
Read More
ProtoKinetix, Incorporated is pleased to announce that it has entered into a research agreement with The University of British Columbia (UBC), under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. This research agreement is to test and determine the effect of AAGP™ on monoclonal antibody production and bone marrow recovery. The University of…
Read More

CBR Visits STEMCELL Technologies

Recently, a lucky group of 26 PhD students and postdocs from the Centre for Blood Research (CBR) attended an all-inclusive tour of STEMCELL technologies. This event, organized by the CBR Educational Program, was a great opportunity to meet and network with various professionals and to learn what a career at STEMCELL Technologies or other similar biotech companies would look like.…
Read More
STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab. Organoids, or ‘mini-organs’, are complex, 3D, in vitro culture models that maintain key structural, developmental and functional similarities to the corresponding intact organs. These innovative models provide specific insight into development and disease mechanisms, and offer opportunities…
Read More
Many people around the world rely on catheters every day to empty their bladder – especially people with spinal cord injuries. After a well-respected publication concluded that catheters could be reused without an increased risk of infection, a professor and researcher from the University of British Columbia began to question. Dr. Andrei Krassioukov, a professor of medicine at UBC and…
Read More
Dr. Moe Elgendi, a postdoctoral fellow and President of the Postdoctoral Association at the University of British Columbia, and Dr. Santa Ono, 15th President and Vice-Chancellor of the University of British Columbia discuss supporting investment in Canada’s basic research. In Dr. Ono’s own words: “It is an outstanding report, which is really a road map for the future of Canada”.
Read More
Precision NanoSystems is one of the fastest growing businesses in British Columbia (BC) according to the recently published Top 100 fastest-growing companies in BC list from business news journalBusiness in Vancouver (BIV). This annual list looks at several factors indicating company growth over the last five years – from changing company revenues to number of employees – and ranks Precision NanoSystems in third…
Read More